| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
61,413,000 |
| Market
Cap: |
8.67(B) |
| Last
Volume: |
854,657 |
Avg
Vol: |
504,733 |
| 52
Week Range: |
$114.17 - $208.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$238,260 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
23,589 |
45,669 |
50,307 |
151,828 |
| Total Sell Value |
$4,058,631 |
$8,416,817 |
$9,119,818 |
$30,980,273 |
| Total People Sold |
2 |
4 |
5 |
6 |
| Total Sell Transactions |
2 |
5 |
7 |
17 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Benjamin Howard |
VP Business Development |
• – – |
2017-03-01 |
4 |
D |
$32.08 |
$63,387 |
D/D |
(1,976) |
31,156 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• – – |
2017-03-01 |
4 |
D |
$32.07 |
$191,524 |
D/D |
(5,972) |
94,858 |
|
- |
|
| Snodgres Jon |
Chief Financial Officer |
• – – |
2017-03-01 |
4 |
D |
$32.07 |
$52,273 |
D/D |
(1,630) |
25,698 |
|
- |
|
| Benjamin Howard |
VP Business Development |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,506 |
33,132 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
32,488 |
100,830 |
|
- |
|
| Snodgres Jon |
Chief Financial Officer |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,875 |
27,328 |
|
- |
|
| Rusche James R |
SENIOR VICE PRESIDENT |
• – – |
2016-12-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
4,700 |
95,816 |
|
- |
|
| Hunt Anthony |
Chief Executive Officer |
• – – |
2016-11-28 |
4 |
AS |
$33.12 |
$165,613 |
D/D |
(5,000) |
68,342 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2016-09-14 |
4 |
S |
$32.58 |
$87,979 |
D/D |
(2,700) |
9,394 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2016-08-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
800 |
8,594 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2016-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
75,764 |
|
- |
|
| Snodgres Jon |
CFO |
• – – |
2016-07-14 |
4 |
D |
$26.56 |
$8,605 |
D/D |
(324) |
17,453 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2016-06-30 |
4 |
S |
$26.60 |
$133,010 |
D/D |
(5,000) |
12,094 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2016-06-28 |
4 |
S |
$24.59 |
$245,888 |
D/D |
(10,000) |
17,094 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2016-06-28 |
4 |
OE |
$3.22 |
$16,100 |
D/D |
5,000 |
27,094 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2016-06-27 |
4 |
D |
$23.46 |
$46,498 |
D/D |
(1,982) |
55,764 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2016-06-27 |
4 |
OE |
$3.10 |
$46,500 |
D/D |
15,000 |
57,746 |
|
- |
|
| Benjamin Howard |
VP Business Development |
– – – |
2016-05-24 |
4 |
OE |
$6.23 |
$62,300 |
D/D |
10,000 |
28,626 |
|
- |
|
| Cox John |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
3,621 |
|
- |
|
| Muir Glenn P |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
1,763 |
|
- |
|
| Ryan Thomas F Jr |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
22,094 |
|
- |
|
| Cooper Glenn L Md |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
37,094 |
|
- |
|
| Barthelemy Nicholas |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,763 |
2,782 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,505 |
42,746 |
|
- |
|
| Benjamin Howard |
VP Business Development |
– – – |
2016-05-11 |
4 |
S |
$26.72 |
$77,199 |
D/D |
(2,889) |
18,626 |
|
- |
|
647 Records found
|
|
Page 16 of 26 |
|
|
4.55 (3.12%) 
